CS-27349, or L-2-α-tropinyl benzilate, is an experimental incapacitating agent. It acts as an antagonist to muscarinic acetylcholine receptors, causing delirium. It has 37% of the potency of the related compound 3-quinuclidinyl benzilate (BZ) in producing peripheral effects, but 85% of the potency in producing central effects. The mean dose required to incapacitate subjects was 1.2 times that of BZ.[1] It has not been in use since the 1970s, and there have been no publications about its effects or long-term toxicology since then.[2]
It is interesting to notice that 2-tropinone is made from cocaine alkaloid.[5] On a related note, it is worthy of mention that 2-tropinone has also had use in the synthesis of isohomoepibatidine and isohomoepiboxidine.[6][7] These are neonicotinoids that were explored as alterntives to epibatidine, which was too toxic for clinical use.
^Atkinson ER, McRitchie-Ticknor DD, Harris LS, Archer S, Aceto MD, Pearl J, et al. (December 1983). "Parasympatholytic (anticholinergic) esters of the isomeric 2-tropanols. 2. Non-glycolates". Journal of Medicinal Chemistry. 26 (12): 1772–1775. doi:10.1021/jm00366a023. PMID6644747.
^US 3145210, Archer S, Bell MR, "Esters of 2-tropanol", issued 18 August 1964, assigned to Sterling Drug Inc.
^Zhang C, Lomenzo SA, Ballay CJ, Trudell ML (1 October 1997). "An Improved Synthesis of (+)-2-Tropinone". The Journal of Organic Chemistry. 62 (22): 7888–7889. doi:10.1021/jo9710083.
^Zhang C, Gyermek L, Trudell ML (August 1997). "Synthesis of optically pure epibatidine analogs: (1R, 2R, 5S)-2β-(2-chloro-5-pyridinyl)-8-azabicyclo[3.2.1]octane and (1R, 2S, 5S)-2α-(2-chloro-5-pyridinyl)-8-azabicyclo[3.2.1]octane from (−)-cocaine". Tetrahedron Letters. 38 (32): 5619–5622. doi:10.1016/S0040-4039(97)01276-8.
^Cheng J, Izenwasser S, Zhang C, Zhang S, Wade D, Trudell ML (April 2004). "Synthesis and nicotinic acetylcholine receptor binding affinities of 2- and 3-isoxazolyl-8-azabicyclo[3.2.1]octanes". Bioorganic & Medicinal Chemistry Letters. 14 (7): 1775–1778. doi:10.1016/j.bmcl.2004.01.025. PMID15026069.